A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment
Mansour Tobaiqy
Topics & Concepts
MedicineAdverse effectAdverse Event Reporting SystemType 2 Diabetes MellitusGlycemicMEDLINEIntensive care medicineType 2 diabetesObesityRandomized controlled trialDiabetes mellitusInternal medicineEndocrinologyLawPolitical scienceDiabetes Treatment and ManagementPharmacology and Obesity TreatmentLipoproteins and Cardiovascular Health